O2h offers synthetic chemistry, FTE-based medicinal and process chemistry including in-vitro biology services to pharmaceutical and biotechnology companies.
Heptares Chemistry head Miles Congreve said O2h has been a valuable partner for the company and they are happy to further extend their synthetic chemistry team to include a full lab unit at O2h.
O2h CEO Sunil Shah said this is a new milestone in their on-going relationship with Heptares and they are excited to support them on their journey.